Synthesis 2008(7): 1133-1141  
DOI: 10.1055/s-2008-1066984
PAPER
© Georg Thieme Verlag Stuttgart · New York

Synthesis of N,N′-Linked Bisazaheterocycles with Sulfonamide Structure via Oxidation of S,N-Heteroaromatic Cations

Valerija M. Zakharovaa, Camino M. González Tanarrob, Michael Gütschowb, Lothar Henniga, Joachim Sielerc, Bärbel Schulze*a
a Institut für Organische Chemie, Universität Leipzig, Johannisallee 29, 04103 Leipzig, Germany
e-Mail: bschulze@chemie.uni-leipzig.de;
b Pharmazeutisches Institut, Pharmazeutische Chemie I, Universität Bonn, An der Immenburg 4, 53121 Bonn, Germany
c Institut für Anorganische Chemie, Universität Leipzig, Johannisallee 29, 04103 Leipzig, Germany
Further Information

Publication History

Received 7 December 2007
Publication Date:
06 March 2008 (online)

Abstract

N-Phthalimidyl- and N-quinazolinyl-substituted 3-hydroperoxy-, 3-hydroxy- and 3-oxoisothiazole 1,1-dioxides have been synthesized by the sequence of oxidation reactions from N,N′-linked isothiazolium perchlorates with hydrogen peroxide, MMPP, and pyridinium dichromate. Isothiazolium salts without acceptor substituents did not give N-substituted sultams. Novel N,N′-bisazaheterocycles were investigated as inhibitors of acetylcholinesterase (AChE) and human leukocyte elastase (HLE). Two 2,3-dihydro-3-hydroperoxy-2-(phthalimid-1-yl)isothiazole 1,1-dioxides were found to inhibit AChE.

    References

  • 1a Khalil MA. El-Din MM. M. Alexandria J. Pharm. Sci.  1989,  3:  190 ; Chem. Abstr. 1991, 114, 62064
  • 1b Obniska J. Jurczyk S. Zeic A. Kaminski K. Tatarczynska E. Stachowicz K. Pharm. Rep.  2005,  57:  170 
  • 2 Effland RC, Davis L, and Olsen GE. inventors; Eur. Pat. Appl. EP 509400,  .  ; Chem. Abstr. 1993, 118, 101970
  • 3a Komatsu M. Yamamoto S. Ohshiro Y. Agawa T. Heterocycles  1985,  23:  677 
  • 3b Bhalla M. Srivastava VK. Bhalla TN. Shanker K. Arzneim. Forsch.  1993,  43:  595 
  • 3c Alcaide B. Miranda M. Perez-Castells J. Polanco C. Sierra MA. J. Org. Chem.  1994,  59:  8003 
  • 3d Tyagy R. Goel B. Srivastava VK. Kumar A. Indian J. Pharm. Sci.  1998,  60:  283 
  • 4a Hoda AA. Sayed AS. Momen AEIK. Ahmed SAY. Phosphorous, Sulfur, Silicon Relat. Elem.  1992,  72:  237 
  • 4b Ibrahim MK. Egyptian J. Pharm. Sci.  1998,  39:  519 
  • 5 Srivastava VK. Singh KS. Singh SN. Fatima N. Chaterjee RK. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem.  1991,  30:  859 
  • 6 Angerbauer R, Huebsch W, Fey P, Bischoff H, Petzinna D, Schmidt D, and Thomas G. inventors; Eur. Pat. Appl. EP  339342.  ; Chem. Abstr. 1990, 113, 115074
  • 7 Srivastava VK. Singh KS. Gulati A. Shanker K. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem.  1987,  26:  652 
  • 8a Reddy GM. Bhavani AKD. Reddy PP. Reddy PSN. Synthesis  2002,  1311 
  • 8b Wang JH. Acc. Chem. Rec.  1970,  3:  90 
  • 8c Inbaraj JJ. Bilski P. Chignell CF. Photochem. Photobiol.  2002,  75:  107 
  • 8d Hawkins CL. Davies MJ. Chem. Res. Toxicol.  2002,  15:  183 
  • 9 Martin L, Kosley RW, Flanagan DM, Kuerzel GU, Nemoto PA, and Wettlaufer DG. inventors; US Patent  5274116.  ; Chem. Abstr. 1994, 121, 280539
  • 10a Martyn DC. Moore MJ. Abell AD. Curr. Pharm. Des.  1999,  5:  405 
  • 10b Gütschow M. Pietsch M. Taubert K. Freysoldt THE. Schulze B. Z. Naturforsch., B: Chem. Sci.  2003,  58:  111 
  • 11 Ashe BM. Clark RL. Jones H. Zimmerman M. J. Biol. Chem.  1981,  256:  11603 
  • 12a Schulze B. Kirrbach S. Illgen K. Fuhrmann P. Tetrahedron  1996,  52:  783 
  • 12b Hartung C. Illgen K. Sieler J. Schneider B. Schulze B. Helv. Chim. Acta  1999,  82:  685 
  • 12c Taubert K. Sieler J. Hennig L. Findeisen M. Schulze B. Helv. Chim. Acta  2002,  85:  183 
  • 12d Taubert K. Siegemund A. Eilfeld A. Baumann S. Sieler J. Schulze B. Synthesis  2004,  2265 
  • 12e Siegemund A. Hartung C. Eilfeld A. Sieler J. Schulze B. Z. Naturforsch., B: Chem. Sci.  2004,  59:  478 
  • 13 Gütschow M. Pietsch M. Themann A. Fahrig J. Schulze B. J. Enz. Inhib. Med. Chem.  2005,  20:  341 
  • 14 Gelalcha FG. Schulze B. J. Org. Chem.  2002,  67:  8400 
  • 15 Muehlstaedt M. Braemer R. Schulze B. Z. Chem.  1976,  16:  49 
  • 16 Zakharova V. Siegemund-Eilfeld A. Sieler J. Schulze B. Z. Naturforsch., B: Chem. Sci.  2006,  61:  464 
  • 17 Baumann S. Moeder M. Herzschuh R. Schulze B. Chromatographia  2003,  57:  147 
  • 18 Kolberg A. Ph. D. Dissertation   Leipzig University; Germany: 1998. 
  • 22 Enders D. Plant A. Backhaus D. Reinhold U. Tetrahedron  1995,  51:  10699 
  • 23 Sheldrick GM. SHELX-97, A Program System for Solution and the Refinement of X-ray Crystal Structures   University of Göttingen; Germany: 1997. 
  • 25 Ellman GL. Courtney KD. Andres V. Feather-Stone RM. Biochem. Pharmacol.  1961,  7:  88 
  • 26 Pietsch M. Gütschow M. J. Med. Chem.  2005,  48:  8270 
19

Crystal data for 15a: C13H16N2O5S; M = 306,3: T = 213 (2) K; λ = 0.71073 Å; Colorless prism; 0.3 × 0.3 × 0.2 mm3; Triclinic; space group P-1; Unit cell dimensions α = 8.030 (2) Å, β = 8.624 (3) Å, c = 10.148 (2) Å, α = 86.81 (2)°, β = 76.02 (2)°, γ = 77.43 (2)°, V = 665.6 (3) Å3, Z = 2, Dcalcd = 1.528 gcm-3; F(000) = 316, µ = 0.267 mm-1; Theta range for data collection 2.4° to 28.2°; Index ranges -10 ≤ h ≤ 10, -11 ≤ k ≤ 11, -13 ≤ l ≤ 13; Reflections collected 6555; Independent reflections 2997 [R int = 0.052]; Final R indices [I >2σ (I)] R1 = 0.0463, wR2 = 0.0626; R indices (all data) R1 = 0.0626, wR2 = 0.1283; Largest diff. Peak/hole 0.335/-0.471 e Å-3.

20

Crystal data for 18d: C16H17N3O4S·H2O; M = 365.4; T = 213 (2) K; λ = 0.71073 Å; Colorless prism; 0.2 × 0.2 × 0.2 mm3; Triclinic; Space group P-1; Unit cell dimensions a = 8.163 (2) Å, b = 8.906 (2) Å, c = 11.862 (4) Å, α = 83.76 (2)°, β = 87.82 (2)°, γ = 81.28 (2)°, V = 847.1 (4) Å3, Z = 2, Dcalcd = 1.433 gcm-3; F(000) = 384, µ = 0.224 mm-1; Theta range for data collection 2.5° to 28.1°; Index ranges -10 ≤ h ≤ 10, -11 ≤ k ≤ 11, -15 ≤ l ≤ 15; Reflections collected 8243; Independent reflections 3779 [Rint = 0.033]; Final R indices [I >2σ(I)] R1 = 0.0363, wR2 = 0.0982; R indices (all data) R1 = 0.0463, wR2 = 0.1018; Largest diff. Peak/hole 0.262/-0.266 e Å-3.

21

Crystal data for 19b: C14H13N3O4S; M = 319.3; T = 213 (2) K; λ = 0.71073 Å; Colorless prism; 0.3 × 0.2 × 0.2 mm3; Orthorhombic; Space group Pna21; Unit cell dimensions a = 10.811 (1) Å, b = 12.632 (1) Å, c = 10.654 (1) Å, V = 1455.0(2) Å3, Z = 4, Dcalcd = 1.458 gcm-3; F(000) = 664, µ = 0.245 mm-1; Theta range for data collection 2.5° to 26.0°; Index ranges -13 ≤ h ≤ 13, -15 ≤ k ≤ 15, -13 ≤ l ≤ 13; Reflections collected 10986; Independent reflections 2828 [Rint = 0.038]; Final R indices [I >2σ (I)] R1 = 0.0259, wR2 = 0.0673; R indices (all data) R1 = 0.0281, wR2 = 0.0681; Largest diff. Peak/hole 0.183/-0.136 e Å-3.

24

The details of the structure analyses for compounds 15a, 18d, and 19b have been deposited at the Cambridge Crystallographic Data Centre with the numbers CCDC-651832, -651831 and -651833, respectively. The copies of the data can be obtained, free of charge, from CCDC, 12 Union Road, Cambridge, CB2 1EZ UK (fax: +44 1233 336033; e-Mail: deposit@ccdc.cam.ac.uk, internet: http://www.ccdc.cam.ac.uk).